Jean Debord
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jean Debord has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Jean-Claude Bollinger
Laboratoire E2Lim (Eau Environnement Limoges), Université de Limoges, 123 Avenue Albert Thomas, 87060 Limoges, France
4 shared publications Michel Harel
Institut Universitaire de Formation des Maîtres, 209 Boulevard de Vanteaux, 87036 Limoges, France
2 shared publicationsThierry Dantoine
2 shared publicationsBernard Pénicaut
Laboratoire de Chimie Analytique, Faculté de Pharmacie, 2 rue du Docteur Marcland, 87025 Limoges Cedex, France
1 shared publicationBernard Verneuil
Laboratoire de Chimie des Substances Naturelles, Faculté des Sciences, 123 Avenue Albert Thomas, 87060 Limoges, France
1 shared publicationChantal Le Guellec
CHU Bretonneau
1 shared publication
Latest Publications
- 1 June 2013
- Published by Elsevier in Thermochimica Acta
- Vol. 561, 49-53
Microcalorimetric study of the inhibition of butyrylcholinesterase by sodium arsenite and zinc chloride: Use of a fractal kinetic model
- 1 June 2013
- Published by Elsevier in Thermochimica Acta
- Vol. 561, 49-53
Microcalorimetric study of the inhibition of butyrylcholinesterase by sodium arsenite and zinc chloride: Use of a fractal kinetic model
- 31 March 2005
- Published by Elsevier in Thermochimica Acta
- Vol. 427 (1-2) , 85-91
Flow microcalorimetric study of enzyme reactions: Application to arylesterase from human serum
- 31 March 2005
- Published by Elsevier in Thermochimica Acta
- Vol. 427 (1-2) , 85-91
Flow microcalorimetric study of enzyme reactions: Application to arylesterase from human serum
- 1 January 2001
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 40 (5) , 375-382
Application of a Gamma Model of Absorption to Oral Cyclosporin
Background: Some drugs, such as cyclosporin, exhibit flat and delayed absorption profiles, with a correlation between the delay and the peak width. Such profiles can be described by an absorption model in which the absorption rate is derived from a gamma distribution (of which the classical first-order absorption model is a special case). Objective: To develop a model for the pharmacokinetics of extravascular administration of cyclosporin and apply it to a study of the pharmacokinetics of cyclosporin microemulsion in stable renal transplant recipients. Patients and participants: 21 renal transplant patients receiving oral cyclosporin microemulsion 75 to 175mg twice daily. Methods: The equation of the plasma concentration-time curve after oral administration was expressed as a convolution product between the absorption rate and a multi-exponential impulse response. The convolution integral was computed analytically and expressed in terms of the incomplete gamma function. Cyclosporin was assayed by liquid chromatography/mass spectrophotometry. The model was fitted by nonlinear regression, using a specially developed program. Results: The gamma model yielded a good fit in all of the 21 patients studied. Attempts to fit the same data by a classical exponential with lag-time model failed in most patients. Conclusions: This model could simplify the Bayesian monitoring of cyclosporin therapy.
- 1 January 2001
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 40 (5) , 375-382
Application of a Gamma Model of Absorption to Oral Cyclosporin
Background: Some drugs, such as cyclosporin, exhibit flat and delayed absorption profiles, with a correlation between the delay and the peak width. Such profiles can be described by an absorption model in which the absorption rate is derived from a gamma distribution (of which the classical first-order absorption model is a special case). Objective: To develop a model for the pharmacokinetics of extravascular administration of cyclosporin and apply it to a study of the pharmacokinetics of cyclosporin microemulsion in stable renal transplant recipients. Patients and participants: 21 renal transplant patients receiving oral cyclosporin microemulsion 75 to 175mg twice daily. Methods: The equation of the plasma concentration-time curve after oral administration was expressed as a convolution product between the absorption rate and a multi-exponential impulse response. The convolution integral was computed analytically and expressed in terms of the incomplete gamma function. Cyclosporin was assayed by liquid chromatography/mass spectrophotometry. The model was fitted by nonlinear regression, using a specially developed program. Results: The gamma model yielded a good fit in all of the 21 patients studied. Attempts to fit the same data by a classical exponential with lag-time model failed in most patients. Conclusions: This model could simplify the Bayesian monitoring of cyclosporin therapy.
- 1 January 1998
- Published by Wiley in Quantitative Structure-Activity Relationships
- Vol. 17 (1) , 01-06
pKa, log Poct and HPLC Capacity Factor on a Porous Polymer Gel in the Study of a Series of 2-Benzamido-5-Nitrothiazoles
- 1 January 1998
- Published by Wiley in Quantitative Structure-Activity Relationships
- Vol. 17 (1) , 01-06
pKa, log Poct and HPLC Capacity Factor on a Porous Polymer Gel in the Study of a Series of 2-Benzamido-5-Nitrothiazoles
- 1 February 1985
- Published by Taylor & Francis in Phosphorus and Sulfur and the Related Elements
- Vol. 22 (1) , 121-130
INHIBITION REVERSIBLE DE LA BUTYRYLCHOLINESTERASE PAR QUELQUES PHOSPHORAMIDES ALIPHATIQUES
The inhibition of horse serum butyrylcholinesterase by 16 aliphatic phosphoramides OPXYZ (with X,Y,Z = Me; NMe2; NHEt; NEt2; has been studied at 30°C and pH 7.4, with a spectrophotometric method using butyrylthiocholine as substrate. The inhibition was always reversible, although an apparent irreversible inhibition was sometimes observed with insufficiently purified inhibitors. Non-linear least-squares analysis of inhibition data showed 13 competitive inhibitors, 2 mixed and 1 non-competitive. The influence of the substituents borne by the phosphoramide molecule upon the competitive inhibition constant is approximately additive, allowing the attribution of a specific increment, δ, to each substituent. There is no correlation between this increment δ and Van der Waals volume Vw or the inductive parameters π and σΦ. However, there is a slight correlation between the competitive inhibition constant and the partition coefficient (octanol/water) of the phosphoramides, suggesting participation of hydrophobic interactions. L'inhibition de la butyrylcholinestérase de sérum de cheval par 16 phosphoramides aliphatiques OPXYZ ( ), a été étudiée à 30°C et à pH 7.4 par une méthode spectrophotométrique avec la butyrylthiocholine comme substrat. L'inhibition est toujours réversible, bien qu'une inhibition irréversible ait parfois été observée avec des inhibiteurs insuffisamment purifiés. L'analyse des données, par la méthode des moindres carrés non linéaire, montre que 13 inhibiteurs sont du type compétitif, 2 mixtes et 1 non-compétitif. L'influence des substituants portés par la molécule de phosphoramide sur la constante d'inhibition compétitive est approximativement additive, ce qui permet d'attribuer un incrément spécifique δ à chaque substituant. II n'y a pas de corrélation entre cet incrément δ et les volumes de van der Waals Vw ou les paramètres inductifs π et σΦ; cependant, il y a une faible corrélation entre la constante d'inhibition compétitive et le coefficient de partage (octanol/eau) des phosphoramides, ce qui suggère la participation d'interactions hydrophobes.
- 1 February 1985
- Published by Taylor & Francis in Phosphorus and Sulfur and the Related Elements
- Vol. 22 (1) , 121-130
INHIBITION REVERSIBLE DE LA BUTYRYLCHOLINESTERASE PAR QUELQUES PHOSPHORAMIDES ALIPHATIQUES
The inhibition of horse serum butyrylcholinesterase by 16 aliphatic phosphoramides OPXYZ (with X,Y,Z = Me; NMe2; NHEt; NEt2; has been studied at 30°C and pH 7.4, with a spectrophotometric method using butyrylthiocholine as substrate. The inhibition was always reversible, although an apparent irreversible inhibition was sometimes observed with insufficiently purified inhibitors. Non-linear least-squares analysis of inhibition data showed 13 competitive inhibitors, 2 mixed and 1 non-competitive. The influence of the substituents borne by the phosphoramide molecule upon the competitive inhibition constant is approximately additive, allowing the attribution of a specific increment, δ, to each substituent. There is no correlation between this increment δ and Van der Waals volume Vw or the inductive parameters π and σΦ. However, there is a slight correlation between the competitive inhibition constant and the partition coefficient (octanol/water) of the phosphoramides, suggesting participation of hydrophobic interactions. L'inhibition de la butyrylcholinestérase de sérum de cheval par 16 phosphoramides aliphatiques OPXYZ ( ), a été étudiée à 30°C et à pH 7.4 par une méthode spectrophotométrique avec la butyrylthiocholine comme substrat. L'inhibition est toujours réversible, bien qu'une inhibition irréversible ait parfois été observée avec des inhibiteurs insuffisamment purifiés. L'analyse des données, par la méthode des moindres carrés non linéaire, montre que 13 inhibiteurs sont du type compétitif, 2 mixtes et 1 non-compétitif. L'influence des substituants portés par la molécule de phosphoramide sur la constante d'inhibition compétitive est approximativement additive, ce qui permet d'attribuer un incrément spécifique δ à chaque substituant. II n'y a pas de corrélation entre cet incrément δ et les volumes de van der Waals Vw ou les paramètres inductifs π et σΦ; cependant, il y a une faible corrélation entre la constante d'inhibition compétitive et le coefficient de partage (octanol/eau) des phosphoramides, ce qui suggère la participation d'interactions hydrophobes.